These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 9101503

  • 1. Intravenous cyclophosphamide pulses in pyoderma gangrenosum: an open trial.
    Reynoso-von Drateln C, Perla-Navarro AV, Gamez-Nava JI, Gonzalez-Lopez L, Galvan-Villegas F, Ramos-Remus C.
    J Rheumatol; 1997 Apr; 24(4):689-93. PubMed ID: 9101503
    [Abstract] [Full Text] [Related]

  • 2. Intravenous cyclophosphamide pulses in the treatment of pyoderma gangrenosum associated with rheumatoid arthritis: report of 2 cases and review of the literature.
    Zonana-Nacach A, Jiménez-Balderas FJ, Martínez-Osuna P, Mintz G.
    J Rheumatol; 1994 Jul; 21(7):1352-6. PubMed ID: 7966084
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Assessment on intermittent intravenous cyclophosphamide pulse therapy in diffuse proliferative lupus nephritis].
    Okubo T, Ideguchi H, Ihata A, Nakamura M, Ueda A, Ohno S, Hagiwara E, Aoki A, Shirai A, Ishigatsubo Y.
    Ryumachi; 2000 Jun; 40(3):605-11. PubMed ID: 10920685
    [Abstract] [Full Text] [Related]

  • 9. [Comparison of various cyclophosphamide treatment regimens on the course and outcome of lupus nephritis ].
    Petrović R, Stojanović R, Novicić-Sasić D, Dimitrijević J, Pavlović S, Stojković D, Palić-Obradović D, Stevanović G, Prodanović S.
    Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():19-25. PubMed ID: 12583309
    [Abstract] [Full Text] [Related]

  • 10. Pyoderma gangrenosum: clinical presentation and outcome in 18 cases and review of the literature.
    Hasselmann DO, Bens G, Tilgen W, Reichrath J.
    J Dtsch Dermatol Ges; 2007 Jul; 5(7):560-4. PubMed ID: 17610605
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of granulocyte and monocyte adsorption apheresis for three cases of refractory pyoderma gangrenosum.
    Seishima M, Mizutani Y, Shibuya Y, Nagasawa C, Aoki T.
    Ther Apher Dial; 2007 Jun; 11(3):177-82. PubMed ID: 17497998
    [Abstract] [Full Text] [Related]

  • 12. Pyoderma gangrenosum associated with hidradenitis suppurativa.
    Ah-Weng A, Langtry JA, Velangi S, Evans CD, Douglas WS.
    Clin Exp Dermatol; 2005 Nov; 30(6):669-71. PubMed ID: 16197385
    [Abstract] [Full Text] [Related]

  • 13. Early diagnosis and early corticosteroid administration improves healing of peristomal pyoderma gangrenosum in inflammatory bowel disease.
    Funayama Y, Kumagai E, Takahashi K, Fukushima K, Sasaki I.
    Dis Colon Rectum; 2009 Feb; 52(2):311-4. PubMed ID: 19279428
    [Abstract] [Full Text] [Related]

  • 14. Poor prognosis of arthritis-associated pyoderma gangrenosum.
    Charles CA, Bialy TL, Falabella AF, Eaglstein WH, Kerdel FA, Kirsner RS.
    Arch Dermatol; 2004 Jul; 140(7):861-4. PubMed ID: 15262699
    [Abstract] [Full Text] [Related]

  • 15. [Pyoderma gangrenosum--an interdisciplinary diagnostic problem].
    Torzecka JD, Kondras K, Dziankowska-Bartkowiak B, Waszczykowska E, Modzelewski B, Jurałowicz P, Kondras M.
    Pol Merkur Lekarski; 2008 Jan; 24(139):34-7. PubMed ID: 18634250
    [Abstract] [Full Text] [Related]

  • 16. Long-term clinical outcomes of synchronized therapy with plasmapheresis and intravenous cyclophosphamide pulse therapy in the treatment of steroid-resistant lupus nephritis.
    Yamaji K, Kim YJ, Tsuda H, Takasaki Y.
    Ther Apher Dial; 2008 Aug; 12(4):298-305. PubMed ID: 18789117
    [Abstract] [Full Text] [Related]

  • 17. Treatment of idiopathic pyoderma gangrenosum with infliximab: induction dosing regimen or on-demand therapy?
    Adişen E, Oztaş M, Gürer MA.
    Dermatology; 2008 Aug; 216(2):163-5. PubMed ID: 18216480
    [Abstract] [Full Text] [Related]

  • 18. Pyoderma gangrenosum: a report of 44 cases with follow-up.
    von den Driesch P.
    Br J Dermatol; 1997 Dec; 137(6):1000-5. PubMed ID: 9470924
    [Abstract] [Full Text] [Related]

  • 19. The use of high-dose immunoglobulin in the treatment of pyoderma gangrenosum.
    Hagman JH, Carrozzo AM, Campione E, Romanelli P, Chimenti S.
    J Dermatolog Treat; 2001 Mar; 12(1):19-22. PubMed ID: 12171682
    [Abstract] [Full Text] [Related]

  • 20. [Pyoderma gangrenosum. 15 cases].
    Riahi I, Mokni M, Haouet S, Cherif F, El Euch D, Azaiz MI, Zitouna MM, Ben Osman-Dhahri A.
    Ann Med Interne (Paris); 2001 Feb; 152(1):3-9. PubMed ID: 11240419
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.